C-support Revenue and Competitors
Estimated Revenue & Valuation
- C-support's estimated annual revenue is currently $37.5M per year.
- C-support's estimated revenue per employee is $270,000
Employee Data
- C-support has 139 Employees.
- C-support grew their employee count by 5% last year.
C-support's People
Name | Title | Email/Phone |
---|
C-support Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $31.1M | 115 | 13% | N/A | N/A |
#2 | $109.4M | 324 | 8% | N/A | N/A |
#3 | $51.1M | 172 | 24% | N/A | N/A |
#4 | $329.6M | 872 | 7% | N/A | N/A |
#5 | $24.3M | 90 | -2% | N/A | N/A |
#6 | $67.1M | 226 | 1% | N/A | N/A |
#7 | $86.7M | 292 | 22% | N/A | N/A |
#8 | $296.4M | 784 | 3% | N/A | N/A |
#9 | $21.6M | 80 | -66% | N/A | N/A |
#10 | $35.6M | 132 | -1% | N/A | N/A |
What Is C-support?
C-support is er voor patiënten die langdurig klachten ondervinden van Covid-19. C-support ondersteunt op alle leefgebieden waarop deze complexe en onbekende ziekte ingrijpt en biedt maatwerk.
keywords:N/AN/A
Total Funding
139
Number of Employees
$37.5M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
C-support News
2022-04-17 - China central bank pledges to support economy amid crippling ...
"China's monetary policy is accommodative and is in a comfortable range. We also stand ready to support small and medium-sized enterprises with...
2022-04-17 - Hepatitis C: Recognizing and Addressing the Stigma
And even if someone is exposed to the virus through drug use, they're deserving of support, not judgment. People who've used drugs face...
2022-04-17 - Historic inflection point' for cultivated meat: UPSIDE Foods closes ...
Historic inflection point' for cultivated meat: UPSIDE Foods closes $400m series C round to support commercial-scale plant with production...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $42.5M | 154 | 25% | N/A |
#2 | $15M | 158 | 17% | N/A |
#3 | $50.1M | 180 | 27% | N/A |
#4 | $31.9M | 200 | 34% | N/A |
#5 | $31.9M | 200 | 34% | N/A |